These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25802580)

  • 1. Two- to 3-Year Follow-Up of ProDisc-L: Results From a Prospective Randomized Trial of Arthroplasty Versus Fusion.
    Zigler JE; Sachs BL; Rashbaum RF; Ohnmeiss DD
    SAS J; 2007; 1(2):63-7. PubMed ID: 25802580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease.
    Zigler J; Delamarter R; Spivak JM; Linovitz RJ; Danielson GO; Haider TT; Cammisa F; Zuchermann J; Balderston R; Kitchel S; Foley K; Watkins R; Bradford D; Yue J; Yuan H; Herkowitz H; Geiger D; Bendo J; Peppers T; Sachs B; Girardi F; Kropf M; Goldstein J
    Spine (Phila Pa 1976); 2007 May; 32(11):1155-62; discussion 1163. PubMed ID: 17495770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumbar total disc arthroplasty in patients older than 60 years of age: a prospective study of the ProDisc prosthesis with 2-year minimum follow-up period.
    Bertagnoli R; Yue JJ; Nanieva R; Fenk-Mayer A; Husted DS; Shah RV; Emerson JW
    J Neurosurg Spine; 2006 Feb; 4(2):85-90. PubMed ID: 16506473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results with ProDisc: European experience and U.S. investigation device exemption study.
    Zigler JE
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S163-6. PubMed ID: 14560187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
    Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B
    Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months.
    Delamarter R; Zigler JE; Balderston RA; Cammisa FP; Goldstein JA; Spivak JM
    J Bone Joint Surg Am; 2011 Apr; 93(8):705-15. PubMed ID: 21398574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
    Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.
    Blumenthal S; McAfee PC; Guyer RD; Hochschuler SH; Geisler FH; Holt RT; Garcia R; Regan JJ; Ohnmeiss DD
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1565-75; discussion E387-91. PubMed ID: 16025024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid- to long-term results of total lumbar disc replacement: a prospective analysis with 5- to 10-year follow-up.
    Siepe CJ; Heider F; Wiechert K; Hitzl W; Ishak B; Mayer MH
    Spine J; 2014 Aug; 14(8):1417-31. PubMed ID: 24448028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumbar spine arthroplasty: early results using the ProDisc II: a prospective randomized trial of arthroplasty versus fusion.
    Zigler JE; Burd TA; Vialle EN; Sachs BL; Rashbaum RF; Ohnmeiss DD
    J Spinal Disord Tech; 2003 Aug; 16(4):352-61. PubMed ID: 12902951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do presence and location of annular tear influence clinical outcome after lumbar total disc arthroplasty? A prospective 1-year follow-up study.
    Yue JJ; Telles C; Schlösser TP; Hermenau S; Ramachandran R; Long WD
    Int J Spine Surg; 2012; 6():13-7. PubMed ID: 25694865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of patients who have undergone 1-Level versus 2-Level ProDisc arthroplasty: a prospective study with minimum of 5-year follow-up.
    Yue J; Zhang K; Bai HX; Du J; Cammisa F; Abjornson C; Mo F
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1194-8. PubMed ID: 23392415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of disabling single-level lumbar discogenic low back pain with total disc arthroplasty utilizing the Prodisc prosthesis: a prospective study with 2-year minimum follow-up.
    Bertagnoli R; Yue JJ; Shah RV; Nanieva R; Pfeiffer F; Fenk-Mayer A; Kershaw T; Husted DS
    Spine (Phila Pa 1976); 2005 Oct; 30(19):2230-6. PubMed ID: 16205353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumbar spine arthroplasty using the ProDisc II.
    Zigler JE
    Spine J; 2004; 4(6 Suppl):260S-267S. PubMed ID: 15541675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ProDisc artificial total lumbar disc replacement: introduction and early results from the United States clinical trial.
    Delamarter RB; Fribourg DM; Kanim LE; Bae H
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S167-75. PubMed ID: 14560188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized multicenter study of cervical arthroplasty versus anterior cervical discectomy and fusion: 5-year results with a metal-on-metal artificial disc.
    Coric D; Guyer RD; Nunley PD; Musante D; Carmody C; Gordon C; Lauryssen C; Boltes MO; Ohnmeiss DD
    J Neurosurg Spine; 2018 Mar; 28(3):252-261. PubMed ID: 29303467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome of lumbar total disc replacement using ProDisc-L in degenerative disc disease: minimum 5-year follow-up results at a single institute.
    Park CK; Ryu KS; Lee KY; Lee HJ
    Spine (Phila Pa 1976); 2012 Apr; 37(8):672-7. PubMed ID: 21857395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of symptomatic adjacent-segment degeneration after lumbar fusion with total disc arthroplasty by using the prodisc prosthesis: a prospective study with 2-year minimum follow up.
    Bertagnoli R; Yue JJ; Fenk-Mayer A; Eerulkar J; Emerson JW
    J Neurosurg Spine; 2006 Feb; 4(2):91-7. PubMed ID: 16506474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study.
    Janssen ME; Zigler JE; Spivak JM; Delamarter RB; Darden BV; Kopjar B
    J Bone Joint Surg Am; 2015 Nov; 97(21):1738-47. PubMed ID: 26537161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of disabling multilevel lumbar discogenic low back pain with total disc arthroplasty utilizing the ProDisc prosthesis: a prospective study with 2-year minimum follow-up.
    Bertagnoli R; Yue JJ; Shah RV; Nanieva R; Pfeiffer F; Fenk-Mayer A; Kershaw T; Husted DS
    Spine (Phila Pa 1976); 2005 Oct; 30(19):2192-9. PubMed ID: 16205346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.